← All organizations

Sagent Pharmaceuticals, Inc.

For profit

Also known as: SAGENT | Sagent Pharmaceuticals Inc. | SAGENT PHARMS | SAGENT PHARMS INC | SAGENT STRIDES

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Nov 9, 2020

Acquired by Nichi-Iko Pharmaceutical Co., Ltd. on Jul 11, 2016

Timeline

2000s

Jun 1, 2007
Sagent Pharmaceuticals, Inc.— Founded

2010s

Aug 10, 2012
vancomycin— Marketing Organization
Jul 11, 2016
Nichi-Iko Pharmaceutical Co., Ltd.— Acquired By
Sep 12, 2017
daptomycin— NDA Secondary Org

Drugs by trial phase (5 distinct, 2 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

camostat mesylate

Indications

Studied for

Muscle Hypotonia

Recent trials (2)

NCT04583592Lead sponsorPhase 2Nov 9, 2020
NCT02449369CollaboratorPhase 4Apr 1, 2015

Details

Founded: Schaumberg, IL, US Jun 1, 2007
Last known activity: Nov 9, 2020